Literature DB >> 20074868

Single versus recurrent depression history: differentiating risk factors among current US smokers.

David R Strong1, Amy Cameron, Shelley Feuer, Amy Cohn, Ana M Abrantes, Richard A Brown.   

Abstract

INTRODUCTION: The strong relationship between persistent tobacco use and Major Depressive Disorder (MDD) has motivated clinical trials of specialized treatments targeting smokers with a history of MDD. Meta-analyses suggest positive responses to specialized treatments have been observed consistently among smokers with history of recurrent rather than a single episode of MDD. Approximately 15% of current US smokers have a history of recurrent MDD. Little is known about the risk factors that contribute to persistent smoking and differentiate these at-risk smokers, US.
METHODS: The National Comorbidity Survey - Replication (NCS-R) included a survey of 1560 smokers participants aged 18 and older in the United States. Lifetime history of MDD was categorized according to chronicity: no history (No MDD), single episode (MDD-S) and recurrent depression (MDD-R). The relationship between the chronicity of MDD, smoking characteristics, cessation history, nicotine dependence, comorbidity with psychiatric disorders, and current functional impairments were examined.
RESULTS: MDD-R smokers reported fewer lifetime cessation efforts, smoked more cigarettes, had higher levels of nicotine dependence, had higher rates of comorbid psychiatric disorders and greater functional impairment than smokers with No MDD. MDD-S smokers were not consistently distinguished from No MDD smokers on cessation attempts, level of daily smoking, nicotine dependence or functional impairment indices.
CONCLUSIONS: The study highlights the importance of chronicity when characterizing depression-related risk of persistent smoking behavior. Although, clinical trials suggest MDD-R smokers specifically benefit from specialized behavioral treatments, these services are not widely available and more efforts are needed to engage MDD-R smokers in efficacious treatments. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20074868      PMCID: PMC2890270          DOI: 10.1016/j.drugalcdep.2009.12.020

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  60 in total

1.  A comparison of the familiality of chronic depression in recurrent early-onset depression pedigrees using different definitions of chronicity.

Authors:  Francis M Mondimore; Peter P Zandi; Dean F MacKinnon; Melvin G McInnis; Erin B Miller; Barbara Schweizer; Raymond P Crowe; William A Scheftner; Myrna M Weissman; Douglas F Levinson; J Raymond DePaulo; James B Potash
Journal:  J Affect Disord       Date:  2006-11-28       Impact factor: 4.839

2.  Bupropion and cognitive-behavioral treatment for depression in smoking cessation.

Authors:  Richard A Brown; Raymond Niaura; Elizabeth E Lloyd-Richardson; David R Strong; Christopher W Kahler; Ana M Abrantes; David Abrams; Ivan W Miller
Journal:  Nicotine Tob Res       Date:  2007-07       Impact factor: 4.244

3.  Tobacco and cannabis co-occurrence: does route of administration matter?

Authors:  Arpana Agrawal; Michael T Lynskey
Journal:  Drug Alcohol Depend       Date:  2008-10-15       Impact factor: 4.492

Review 4.  Sex differences in long-term smoking cessation rates due to nicotine patch.

Authors:  Kenneth A Perkins; John Scott
Journal:  Nicotine Tob Res       Date:  2008-07       Impact factor: 4.244

5.  The importance of timing of transitions for risk of regular smoking and nicotine dependence.

Authors:  Lisa Dierker; Jianping He; Amanda Kalaydjian; Joel Swendsen; Louisa Degenhardt; Meyer Glantz; Kevin Conway; James Anthony; Wai Tat Chiu; Nancy A Sampson; Ronald Kessler; Kathleen Merikangas
Journal:  Ann Behav Med       Date:  2008-08-13

6.  Gender differences in the comorbidity of smoking behavior and major depression.

Authors:  Mathilde M Husky; Carolyn M Mazure; Prashni Paliwal; Sherry A McKee
Journal:  Drug Alcohol Depend       Date:  2007-09-11       Impact factor: 4.492

7.  Consistency of self-reported smoking over a 6-year interval from adolescence to young adulthood.

Authors:  Cassandra A Stanton; George Papandonatos; Elizabeth E Lloyd-Richardson; Raymond Niaura
Journal:  Addiction       Date:  2007-09-03       Impact factor: 6.526

8.  Linking measures of adolescent nicotine dependence to a common latent continuum.

Authors:  David R Strong; Christopher W Kahler; Suzanne M Colby; Pamela C Griesler; Denise Kandel
Journal:  Drug Alcohol Depend       Date:  2008-10-19       Impact factor: 4.492

9.  Classification of depressive disorders in the DSM-V: proposal for a two-dimension system.

Authors:  Daniel N Klein
Journal:  J Abnorm Psychol       Date:  2008-08

10.  The role of psychiatric disorders in the relationship between cigarette smoking and DSM-IV nicotine dependence among young adults.

Authors:  Lisa Dierker; Eric Donny
Journal:  Nicotine Tob Res       Date:  2008-03       Impact factor: 4.244

View more
  3 in total

1.  Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial.

Authors:  A Eden Evins; Neal L Benowitz; Robert West; Cristina Russ; Thomas McRae; David Lawrence; Alok Krishen; Lisa St Aubin; Melissa Culhane Maravic; Robert M Anthenelli
Journal:  J Clin Psychopharmacol       Date:  2019 Mar/Apr       Impact factor: 3.153

2.  Depressive symptoms among heavy cigarette smokers: the influence of daily rate, gender, and race.

Authors:  Thomas J Payne; Jennie Z Ma; Karen M Crews; Ming D Li
Journal:  Nicotine Tob Res       Date:  2013-04-08       Impact factor: 4.244

Review 3.  Smoking cessation and reduction in people with chronic mental illness.

Authors:  Jennifer W Tidey; Mollie E Miller
Journal:  BMJ       Date:  2015-09-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.